Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)
Completed · Phase 2 · Has a placebo group
Conditions studied: Diabetic Peripheral Neuropathic Pain
In brief
To evaluate the efficacy of NYX-2925 versus placebo in treating the neuropathic pain associated with diabetic peripheral neuropathy.
Key facts
- Study ID
- NCT04146896
- Run by
- Aptinyx
- People needed
- 228
- Starts
- 2019-11-12
- Expected to finish
- 2022-02-23
- Last updated by the study team
- 2023-04-28
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Informed consent
- Subject has diabetic peripheral neuropathy of symmetrical nature in lower extremities for ≥4 years and reports at least moderate pain over the last week
- Stable diabetic and protocol allowed medication during the study
- Agrees to use highly effective birth control during the study
- Has not participated in an interventional study for at least 30 days and agrees not to participate in another interventional study during the study
You may not qualify if…
- Pain due to other conditions or diseases that would complicate participation in the study or pain reporting
- Current or historical serious medical conditions
- Prior participation in NYX-2925 clinical trial
Where it is running
- Aptinyx Clinical Site — Fresno, California, United States
- Aptinyx Clinical Site — Irvine, California, United States
- Aptinyx Clinical Site — Lomita, California, United States
- Aptinyx Clinical Site — Los Angeles, California, United States
- Aptinyx Clinical Site — Norco, California, United States
- Aptinyx Clinical Site — Pomona, California, United States
- Aptinyx Clinical Site — Santa Ana, California, United States
- Aptinyx Clinical Site — Tustin, California, United States
- Aptinyx Clinical Site — Brandon, Florida, United States
- Aptinyx Clinical Site — Clearwater, Florida, United States
- Aptinyx Clinical Site — Greenacres City, Florida, United States
- Aptinyx Clinical Site — Miami, Florida, United States
- Aptinyx Clinical Site — Miami, Florida, United States
- Aptinyx Clinical Site — New Port Richey, Florida, United States
- Aptinyx Clinical Site — Tampa, Florida, United States
- Aptinyx Clinical Site — Tampa, Florida, United States
- Aptinyx Clinical Site — Winter Haven, Florida, United States
- Aptinyx Clinical Site — Winter Park, Florida, United States
- Aptinyx Clinical Site — Decatur, Georgia, United States
- Aptinyx Clinical Site — Marietta, Georgia, United States
- Aptinyx Clinical Site — Blackfoot, Idaho, United States
- Aptinyx Clinical Site — Flossmoor, Illinois, United States
- Aptinyx Clinical Site — Rochester, Michigan, United States
- Aptinyx Clinical Site — Hazelwood, Missouri, United States
- Aptinyx Clinical Site — Las Vegas, Nevada, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.